Special Immunization Considerations of the Preterm Infant

Journal of Pediatric Health Care

Volumn 21, Issue 6, 2007, Pages 385-391

  Gad, Ashraf ^a   Shah, Shetal ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ARTICLE; HOSPITAL DISCHARGE; HUMAN; IMMUNIZATION; IMMUNOLOGY; INFANT; NEWBORN; PRACTICE GUIDELINE; PREMATURITY; PRESCHOOL CHILD; UNITED STATES;

CHILD, PRESCHOOL; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; PATIENT DISCHARGE; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; VACCINES, COMBINED;

EID: 35549003195     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedhc.2007.05.005     Document Type: Article

References (49)

1. Advisory Committee on Immunization Practices. Use of vaccines and immune globulins for persons with altered immunocompetence. Morbidity and Mortality Weekly Report 42 RR-4 (1993) 1-18
2. Advisory Committee on Immunization Practices. Withdrawal of rotavirus vaccine recommendation. Morbidity and Mortality Weekly Report 48 (1999) 1007
3. Advisory Committee on Immunization Practices. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Part 1: Immunization of infants, children, and adolescents. Morbidity and Mortality Weekly Report 54 RR-16 (2005) 1-31
4. Advisory Committee on Immunization Practices. Preventing tetanus, diphtheria, and pertussis among adolescents: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Morbidity and Mortality Weekly Report 55 RR-3 (2006) 1-34
5. Advisory Committee on Immunization Practices. Preventing tetanus, diphtheria, and pertussis among adults: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. Morbidity and Mortality Weekly Report 55 RR-17 (2006) 1-37
6. Advisory Committee on Immunization Practices. Prevention and control of influenza. Morbidity and Mortality Weekly Report 55 RR-10 (2006) 1-42
7. Advisory Committee on Immunization Practices. Prevention of rotavirus gastroenteritis among infants and children. Morbidity and Mortality Weekly Report 55 RR-12 (2006) 1-13
8. American Academy of Pediatrics. Hepatitis B (Red Book). 26th ed. (2003), Author, Elk Grove Village, IL
9. Bernbaum J., Daft A., Samuelson J., and Polin R.A. Half-dose immunization for diphtheria, tetanus, pertussis: Response of preterm infants. Pediatrics 83 (1989) 471-476
10. Bhat N., Wright J.G., Broder K.R., Murray E.L., Greenberg M.E., Glover M.J., et al. Influenza-associated deaths among children in the United States, 2003-2004. The New England Journal of Medicine 353 (2005) 2559-2567
11. Bisgard K.M., Pascual F.B., Ehresmann K.R., Miller C.A., Cianfrini C., Jennings C.E., et al. Infant pertussis: Who was the source?. The Pediatric Infectious Disease Journal 23 (2004) 985-989
12. Campion E.W. Suspicions about the safety of vaccines. The New England Journal of Medicine 347 (2002) 1474-1475
13. Dales L., Hammer S.J., and Smith N.J. Time trends in autism and in MMR immunization coverage in California. The Journal of the American Medical Association 285 (2001) 1183-1185
14. Davis R.L., Rubanowice D., Shinefield H.R., Lewis N., Gu D., Black S.B., et al. Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization status. Centers for Disease Control and Prevention Vaccine Safety Datalink Group. The Journal of the American Medical Association 282 (1999) 547-553
15. Ehrenkranz R.A., Younes N., Lemons J.A., Fanaroff A.A., Donovan E.F., Wright L.L., et al. Longitudinal growth of hospitalized very low birth weight infants. Pediatrics 104 2 Pt 1 (1999) 280-289
16. Gonzalez M., Pirez M.C., Ward E., Dibarboure H., Garcia A., and Picolet H. Safety and immunogenicity of a paediatric presentation of an influenza vaccine. Archives of Disease in Childhood 83 (2000) 488-491
17. Groseclose S.L., Brathwaite W.S., Hall P.A., Connor F.J., Sharp P., Anderson W.J., et al. Summary of notifiable diseases-United States, 2002. Morbidity and Mortality Weekly Report 51 53 (2004) 1-84
18. Hewlett E.L., and Edwards K.M. Clinical practice. Pertussis-not just for kids. The New England Journal of Medicine 352 (2005) 1215-1222
19. Huang F.Y., Lee P.I., Lee C.Y., Huang L.M., Chang L.Y., and Liu S.C. Hepatitis B vaccination in preterm infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 77 (1997) F135-F138
20. Izurieta H.S., Thompson W.W., Kramarz P., Shay D.K., Davis R.L., DeStefano F., et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. The New England Journal of Medicine 342 (2000) 232-239
21. Kirmani K.I., Lofthus G., Pichichero M.E., Voloshen T., and D'Angio C.T. Seven-year follow-up of vaccine response in extremely premature infants. Pediatrics 109 (2002) 498-504
22. Langkamp D.L., Hoshaw-Woodard S., Boye M.E., and Lemeshow S. Delays in receipt of immunizations in low-birth-weight children: A nationally representative sample. Archives of Pediatrics & Adolescent Medicine 155 (2001) 167-172
23. Lee B.P., Azimi P.H., Staat M.A., Louie L., Parada E., Berke T., et al. Nonmedical costs associated with rotavirus disease requiring hospitalization. The Pediatric Infectious Disease Journal 24 (2005) 984-988
24. Lee G.M., Lebaron C., Murphy T.V., Lett S., Schauer S., and Lieu T.A. Pertussis in adolescents and adults: Should we vaccinate?. Pediatrics 115 (2005) 1675-1684
25. Linder N., Vishne T.H., Levin E., Handsher R., Fink-Kremer I., Waldman D., et al. Hepatitis B vaccination: Long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocols. Infection 30 (2002) 136-139
26. Madsen K.M., Hviid A., Vestergaard M., Schendel D., Wohlfahrt J., Thorsen P., et al. A population-based study of measles, mumps, and rubella vaccination and autism. The New England Journal of Medicine 347 (2002) 1477-1482
27. Neuzil K.M., Mellen B.G., Wright P.F., Mitchel Jr. E.F., and Griffin M.R. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. The New England Journal of Medicine 342 (2000) 225-231
28. Newman R.D., Grupp-Phelan J., Shay D.K., and Davis R.L. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics 103 (1999) E3
29. Offit P.A., Quarles J., Gerber M.A., Hackett C.J., Marcuse E.K., Kollman T.R., et al. Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system?. Pediatrics 109 (2002) 124-129
30. Pelosi J.W., and Schulte J.M. Use of birth certificates and surveillance data to characterize reported pertussis among Texas infants and young children, 1995 to 2000. Southern Medical Journal 96 (2003) 1231-1237
31. Prober C.G. Clinical approach to the infected neonate (Principles and practice of pediatric infectious diseases ed.) (1997), Churchill Livingstone Inc, New York, NY
32. Pullan C.R., and Hull D. Routine immunization of preterm infants. Archives of Disease in Childhood 64 (1989) 1438-1441
33. Ramsay M.E., Miller E., Ashworth L.A., Coleman T.J., Rush M., and Waight P.A. Adverse events and antibody response to accelerated immunisation in term and preterm infants. Archives of Disease in Childhood 72 (1995) 230-232
34. Saari T.N. Immunization of preterm and low birth weight infants. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 112 1 Pt 1 (2003) 193-198
35. Schloesser R.L., Fischer D., Otto W., Rettwitz-Volk W., Herden P., and Zielen S. Safety and immunogenicity of an acellular pertussis vaccine in premature infants. Pediatrics 103 (1999) e60
36. Shah S., and Caprio M. Optimizing long-term care by administration of influenza vaccine to parents of NICU patients. Journal of Perinatology 24 (2004) 273-274
37. Slack M.H., and Schapira D. Severe apneas following immunisation in premature infants. Archives of Disease in Childhood, Fetal and Neonatal Edition 81 (1999) F67-F68
38. Slack M.H., Schapira D., Thwaites R.J., Schapira C., Bamber J., Burrage M., et al. Acellular pertussis vaccine given by accelerated schedule: Response of preterm infants. Archives of Disease in Childhood, Fetal and Neonatal Edition 89 (2004) F57-F60
39. Talbot T.R., Crocker D.D., Peters J., Doersam J.K., Ikizler M.R., Sannella E., et al. Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults. Infection Control and Hospital Epidemiology 26 (2005) 494-500
40. Tan T., Halperin S., Cherry J.D., Edwards K., Englund J.A., Glezen P., et al. Pertussis immunization in the global pertussis initiative North American region: Recommended strategies and implementation considerations. The Pediatric Infectious Disease Journal 24 (2005) S83-S86
41. Tanaka M., Vitek C.R., Pascual F.B., Bisgard K.M., Tate J.E., and Murphy T.V. Trends in pertussis among infants in the United States, 1980-1999. The Journal of the American Medical Association 290 (2003) 2968-2975
42. Taylor B., Miller E., Lingam R., Andrews N., Simmons A., and Stowe J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: Population study. British Medical Journal 324 (2002) 393-396
43. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. The Journal of the American Medical Association 292 (2004) 1333-1340
44. Tillmann B.U., Tillmann H.C., Nars P.W., and Weber P. Vaccination rate and age of premature infants weighing <1500 g: A pilot study in north-western Switzerland. Acta Paediatrica 90 (2001) 1421-1426
45. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. The New England Journal of Medicine 354 (2006) 23-33
46. Wakefield A.J., Murch S.H., Anthony A., Linnell J., Casson D.M., Malik M., et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351 (1998) 637-641
47. Wolfe R.M., Sharp L.K., and Lipsky M.S. Content and design attributes of antivaccination web sites. The Journal of the American Medical Association 287 (2002) 3245-3248
48. Wortis N., Strebel P.M., Wharton M., Bardenheier B., and Hardy I.R. Pertussis deaths: Report of 23 cases in the United States, 1992 and 1993. Pediatrics 97 (1996) 607-612
49. Yusuf H.R., Daniels D., Smith P., Coronado V., and Rodewald L. Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series. The Journal of the American Medical Association 284 (2000) 978-983